boosting Oncology investigation with built-in KRAS Assay solutions and RAS Assays
while in the quickly evolving field of oncology investigate, exact and economical mutation screening is very important for producing qualified therapies. The KRAS companies System performs a pivotal role Within this landscape by providing thorough options for KRAS mutation profiling and Investigation. KRAS mutations, present in about ninety five% o